These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7337927)

  • 21. Synthesis, characterization, and anti-bacterial efficacy of some novel cyclophane amide.
    Rajakumar P; Rasheed AM; Balu PM; Murugesan K
    Bioorg Med Chem; 2006 Nov; 14(22):7458-67. PubMed ID: 16879971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of thienamycin.
    Shah PM
    Methods Find Exp Clin Pharmacol; 1981; 3(6):387-90. PubMed ID: 7329164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridone-carboxylic acids as antibacterial agents. I. Synthesis and antibacterial activity of 1-alkyl-1,4-dihydro-4-oxo-1,8- and 1,6-naphthyridine-3-carboxylic acids.
    Hirose T; Mishio S; Matsumoto J; Minami S
    Chem Pharm Bull (Tokyo); 1982 Jul; 30(7):2399-409. PubMed ID: 7139814
    [No Abstract]   [Full Text] [Related]  

  • 24. Sch 29482, laboratory evaluation of a new penem antibiotic.
    Kayser FH; Kuhn I
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():181-8. PubMed ID: 7061368
    [No Abstract]   [Full Text] [Related]  

  • 25. In-vitro activity of Sch 29482--a new penem antibiotic.
    Muench RL; Mayhew AL; Hindler JA; Hewitt WL; Young LS
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():71-8. PubMed ID: 7061378
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative in-vitro activity of Sch 29482, a new penem antibiotic.
    Reeves DS; Bywater MJ; Holt HA
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():31-40. PubMed ID: 7061375
    [No Abstract]   [Full Text] [Related]  

  • 27. Sch 29482, a new oral penem: comparative in-vitro activity, beta-lactamase stability and inhibition.
    Barry AL; Jones RN; Wilson HW; Badal RE; Thornsberry C
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():97-112. PubMed ID: 6977536
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro and in vivo evaluation of the penem FCE 22101 and its orally absorbed ester FCE 22891.
    Bruna CD; Jabes D; Sebben G; Sanfilippo A
    G Ital Chemioter; 1983; 30(2-3):125-30. PubMed ID: 6329870
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibacterial activity of an oral penem, Sch 29482.
    Neu HC; Labthavikul P
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():49-57. PubMed ID: 6977533
    [No Abstract]   [Full Text] [Related]  

  • 30. Carbapenem and penem antibiotics. II. Synthesis and antibacterial activity of 2-functionalized-methyl carbapenems related to asparenomycins.
    Imuta M; Ona H; Uyeo S; Motokawa K; Yoshida T
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4361-70. PubMed ID: 4092265
    [No Abstract]   [Full Text] [Related]  

  • 31. Carbapenem and penem antibiotics. I. Total synthesis and antibacterial activity of dl-asparenomycins A, B and C and related carbapenem antibiotics.
    Ona H; Uyeo S; Motokawa K; Yoshida T
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4346-60. PubMed ID: 4092264
    [No Abstract]   [Full Text] [Related]  

  • 32. Sch 29482, a new penem antibiotic: evaluation of in-vitro activity and effect of test conditions.
    Hare RS; Miller GH; Naples L; Sabatelli F; Loebenberg D; Waitz JA
    J Antimicrob Chemother; 1982 Feb; 9 Suppl C():7-16. PubMed ID: 7061377
    [No Abstract]   [Full Text] [Related]  

  • 33. Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria.
    Piddock LJ; Johnson MM; Webber MA
    J Antimicrob Chemother; 2003 Sep; 52(3):500-2. PubMed ID: 12917244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams.
    Ekström B
    Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbapenem and penem antibiotics. III. Synthesis and antibacterial activity of 2-functionalized-methyl penems related to asparenomycins.
    Imuta M; Uyeo S; Nakano M; Yoshida T
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4371-81. PubMed ID: 4092266
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on penem and carbapenem. I. Syntheses and oral absorption of ester-type prodrugs of sodium (5R,6S)-2-(2-fluoroethylthio)-6-[(1R)-1-hydroxyethyl]penem-3-c arboxylat e.
    Miyauchi M; Endo R; Watanabe K; Kawahara Y; Iwata M; Kawamoto I
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1587-90. PubMed ID: 2208369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monobactams--structure-activity relationships leading to SQ 26,776.
    Breuer H; Cimarusti CM; Denzel T; Koster WH; Slusarchyk WA; Treuner UD
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():21-8. PubMed ID: 7199044
    [No Abstract]   [Full Text] [Related]  

  • 38. An overlay gel method for identification and isolation of bacterial beta-lactamases.
    Eftekhar F; Rafiee R
    J Microbiol Methods; 2006 Jan; 64(1):132-4. PubMed ID: 15927292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of holomycin and derivatives.
    Ellis JE; Fried JH; Harrison IT; Rapp E; Ross CH
    J Org Chem; 1977 Aug; 42(17):2891-3. PubMed ID: 894386
    [No Abstract]   [Full Text] [Related]  

  • 40. Pyrrolnitrin analogues. IX. Synthesis and biological activity of 1-tolyl-3-nitrophenyl-5-methylpyrazole-4-carboxylic acids and 1-tolyl-3-methyl-5-nitrophenylpyrazole-4-carboxylic acids.
    Cecchi L; Melani F; Palazzino G; Filacchioni G; Porretta GC
    Farmaco Sci; 1984 Oct; 39(10):888-900. PubMed ID: 6510520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.